Comparative transcriptome analysis of kidney tissue from CKD and non-CKD models of FGF23 excess have identified the activation of common pathways associated with fibrosis and inflammation, including transforming growth factor (TGF)-β1 related signalling30, a master regulator of fibrosis31. Here, FGF23 is linked to chronic kidney disease.